LJPC

La Jolla Pharmaceutical Company
LJPC

Overview Fund Activity
Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

73 hedge funds and large institutions have $256M invested in La Jolla Pharmaceutical Company in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 7 closing their positions.

Holders
73
Holders Change
+3
Holders Change %
+4.29%
% of All Funds
1.95%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
10
Increased
30
Reduced
17
Closed
7
Calls
$3.57M
Puts
$1.22M
Net Calls
+$2.34M
Net Calls Change
+$1.44M

Top Buyers

1
PA
1
Perceptive Advisors
New York
$21.3M
2
JHIU
2
Janus Henderson Investors US
Colorado
$19.9M
3
BC
3
Broadfin Capital
New York
$20.5M
4
SM
4
Sabby Management
Florida
$3.3M
5
Allianz Asset Management
5
Allianz Asset Management
Germany
$9.07M

Top Sellers

1
VAM
1
Visium Asset Management
New York
$0
2
ACA
2
Avoro Capital Advisors
New York
$1.12M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$41.9M
4
OAM
4
Oxford Asset Management
United Kingdom
$646K
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
76
Goldman Sachs
New York
– -$329K -15,743 Closed
Squarepoint
77
Squarepoint
New York
– -$303K -14,500 Closed
Balyasny Asset Management
78
Balyasny Asset Management
Illinois
– -$264K -12,630 Closed
Walleye Trading
79
Walleye Trading
New York
– -$2K -100 Closed
1 2 3
4